Development of unimolecular nanoparticle-mediated periadventitial drug delivery system for sustained and targeted inhibition of intimal hyperplasia following open vascular reconstruction
$168,300R01FY2019HLNIH
University Of Virginia, Charlottesville VA
Investigators
Linked publications, trials & patents
Paper 39461367Paper 37467597Paper 35169042Paper 34711811Paper 34416322Paper 34286726Paper 34174352Paper 34153787Paper 33615323Paper 33234676Paper 33072177Paper 32979792Paper 32871430Paper 32799103Paper 32380204Paper 32306814Paper 32215348Paper 31523868Paper 31513972Paper 31501532Paper 31080110Paper 31075399Paper 30784274Paper 30623138Paper 30592619Paper 30383455Paper 30222305Paper 30184544Paper 30009887Paper 29958152Paper 29798662Paper 28613846Paper 28165488Paper 28159516Paper 28063892Paper 27179635Patent 12616656Patent 12582613Patent 11446392
View original record on NIH RePORTER →